TABLE 2.
Candidate genes |
Locationb |
Known functions | Known roles in mononuclear phagocytes | References | ||
---|---|---|---|---|---|---|
Gene symbola | Gene name | Human T1D | Mouse NOD | |||
AFF3 | AF4/FMR2 family, member 3 | 2q11.2 | chr1 | May function as nuclear transcriptional activator in lymphoid and brain development | Is expressed in pDCs | [45] |
Idd26 | ||||||
BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | 6q15 | chr4 | Is a transcriptional regulator that mediates B cell lineage development and represses CD4+ T cell differentiation | Regulates M1–M2 polarization; Bach2-deficient alveolar macrophages show enhanced cholesterol uptake and recruitment into lung | [46] |
BAD | BCL2-associated agonist of cell death | 11q13.1 | chr19 | Mediates proapoptotic signaling by forming heterodimers with BCL-xL and BCL-2 | Mediates LPS/CpG-induced apoptosis in BM-DCs | [47] |
C1QTNF6 | C1q and TNF-related protein 6, CTRP6 | 22q12.3 | chr15 | Is an adiponectin paralog that can modulate metabolism, inflammation, and angiogenesis | Treatment of CTRP6 induces IL-10 production in human macrophage cell lines | [48] |
CD226 | CD226 molecule, DNAM-1 | 18q22.2 | chr18 | Stimulates NK cell-mediated cytotoxicity; expressed mainly on NK cells, platelets, T cells, and monocytes | Cross-linking CD226 mediates maturation of CD8α+ DCs | [49] |
Idd21.1 | ||||||
CD69 | CD69 molecule | 12p13.31 | chr6 | Regulates lymphocyte proliferation | Inhibits sphingosine-1-phosphate-induced skin DC migration; is expressed by pDCs | [50, 51] |
CLEC16A | C-type lectin domain family 16, member A | 16p13.13 | chr16 | Predominately expressed in DCs, B cells, and NK cells; is involved in the costimulation and activation of T cells | Promotes late endosomal maturation to drive MHC class II expression in human monocyte DCs | [52] |
CTSH | Cathepsin H | 15q25.1 | chr9 | Increases insulin and protects against cytokine-induced apoptosis in islet β cells | Is required for MHC-II antigen presentation in APCs; higher expression in hCD1c+ cDCs compared with hCD141+ cDCs | [53–55] |
Idd2 | ||||||
DEXI | Dexi homolog (mouse) | 16p13.13 | chr16 | Unknown function; induced by dexamethasone; risk allele corresponds with lower DEXI mRNA expression | Is highly expressed on DCs and monocytes | [56] |
DLK1 | δ-like 1 homolog (Drosophila), δ-1 | 14q32.2 | chr12c | Mediates normal adipogenesis, muscular and neuronal differentiation, bone differentiation, and hematopoiesis | Promotes human mDC differentiation; promotes Th1 differentiation through interaction with Notch1 on T cells | [57] |
IL2RA | IL-2 receptor, α | 10p15.1 | chr2 | Induces cell proliferation, differentiation, and survival/apoptosis | Blocking reduces LPS-stimulated inflammatory cytokines and Th1 priming by DCs; IL2RA+IDO+ DCs suppress T cell proliferation | [58] |
IDDM21 | ||||||
IL7R | IL-7 receptor | 5p13.2 | chr15 | IL-7 is a growth factor for lymphoid progenitors; induces homeostatic T cell proliferation | Is required for cDC and pDC development from CLPs; down-regulates MHC expression on DCs | [59, 60] |
NRP1 | Neuropilin 1, BDCA-4 | 10p11.22 | chr8 | Is expressed in human pDCs, moDCs, and Tregs; is the receptor for Sema3A, VEGF and LAP-TGF-β1 | Increases contact between resting T cells/Tregs and DCs; is transferred from DCs to T cells by trogocytosis | [61, 62] |
ORMDL3 | ORMDL sphingolipid biosynthesis regulator 3 | 17q12 | chr11 | Is involved in ER stress and inflammation; regulates eosinophil recruitment and degranulation in allergic asthma | Is induced on lung macrophages during allergic inflammation and increases chemokine expression | [63] |
PTPN2 | Protein tyrosine phosphatase, nonreceptor type 2 | 18p11.21 | chr18 | Is a negative regulator of tyrosine kinases that signal downstream of cytokine and antigen receptors; inactivates JAK/STAT signal | Suppresses CSF-1–mediated mononuclear phagocyte development | [64, 65] |
Idd21.2 | ||||||
PTPN22 | Protein tyrosine phosphatase, nonreceptor type 22 | 1p13.2 | chr3 | Negatively regulates TCR signal in T cells; risk allele gives increase in memory/effector T cells | PTPN22 loss of function results in DC hyporesponsiveness | [66, 67] |
Idd18.2 | ||||||
RAC2 | Ras-related C3 botulinum toxin substrate 2 (Rho family, small GTP binding protein Rac2) | 22q12.3 | chr15 | Is a plasma membrane protein that regulates cell secretion, phagocytosis, and polarization | Rac2 deficiency in DCs impaired migration toward T cells and T cell priming; required for phagosomal pH regulation and cross-presentation in CD8+ DCs | [68, 69] |
RASGRP1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) | 15q14 | chr2 | Regulates Ras activation in lymphocytes, a central determinant of Ag receptor signal strength | Is up-regulated by TLR agonists in macrophages and limits TLR-mediated inflammation | [70] |
Idd13 | ||||||
TAGAP | T cell activation Rho GTPase activating protein | 6q25.3 | chr17 | Is a negative regulator that mediates Rho GTPase signaling in activated T cells and other immune cells | Tagap deficiency in macrophages reduces inflammatory responses, including IFN-β, and increased virus replication | [71] |
IDDM21 | Idd23 | |||||
TNFAIP3 | TNF-α–induced protein 3, A20 | 6q23.3 | chr10c | Tnfaip3 deficient DCs are spontaneously activated and produce high levels of proinflammatory cytokines | Tnfaip3 deficiency in DCs causes systemic autoimmunity in mice | [72, 73] |
TYK2 | Tyrosine kinase 2 | 19p13.2 | chr9 | Acts as JAK kinase for STAT signal for IFN-α, IL-12/IL-23, IL-10, GM-CSF stimulation | Tyk2 deficiency in DCs impaired Th1 differentiation | [94] |
BM-DCs, bone marrow-derived DCs; moDCs, monocyte-derived DCs.
Genes not in bold (BACH2 and C1QTNF6) show DC gene expression by ImmGen database, but no other publications confirm DC expression.
Where applicable, the relevant human IDDM or mouse Idd locus is given.
Mouse DlK1 and TNFAIP3 have not been shown to affect NOD diabetes susceptibility.